Browse drugs

…ally, as demonstrated by several ENDS marketed today. Combining nicotine flux and puff duration regulation is feasible today and provide…

…ating skin reactions is crucial in topical product development. Turmeric/epigallocatechin-3-gallate (EGCG) emulgel demonstrates therapeutic potential for cutaneous diseases, warr…

…olved after 1 week of pentobarbital coma. She was discharged on Clobazam, Perampanel and Lacosamide, with persistent hypotonia and rare …

…nd household relationships. Women will receive three bottles of MMS (180 tablets each) over 18 months. Quantitative data collection…

…t loss, lifestyle changes and semaglutide treatment. To receive semaglutide treatment, patients were required to participate in GCs focused…

…nduct safety assessments and (iii) evaluate the efficacy of the metformin and SBRT combination.Methods and analysis We conducted a prospe…

…term tumor control compared with CAR-NK cells supplemented with IL-15. Similar results were seen using C7R-expressing CD19.CAR-NK cel…

… there was significant geographical variation in yields of both B+ and AF-TB, supporting targeting of interventions in areas of hi…

…se volatile agent with continuous infusions of remifentanil and rocuronium. This approach ensured stable haemodynamics, adequate sedation …

…The most common symptoms were reflux (32%) and dysphagia (28%). Proton pump inhibitor use was high (81%). Both anticentromere (p=<0.001) and anti-Scl…

…her CFNB or CACB. All patients received a 20 mL loading dose of 0.5% ropivacaine and were discharged with a 0.2% ropivacaine infusion (5 mL/hour…

…nimal Mycology (ISHAM) guidelines. The patient was treated with itraconazole and a tapering course of oral prednisolone. At the 6-month foll…